Disease areas:
  • bones, joints and muscles
  • brain
  • genetic diseases
  • heart and blood vessels
  • mental health
Last updated:
Author(s):
Matthew Aguirre, Manuel A Rivas, James Priest
Publish date:
25 July 2019
Journal:
American Journal of Human Genetics
PubMed ID:
31353025

Abstract

Copy-number variations (CNVs) represent a significant proportion of the genetic differences between individuals and many CNVs associate causally with syndromic disease and clinical outcomes. Here, we characterize the landscape of copy-number variation and their phenome-wide effects in a sample of 472,228 array-genotyped individuals from the UK Biobank. In addition to population-level selection effects against genic loci conferring high mortality, we describe genetic burden from potentially pathogenic and previously uncharacterized CNV loci across more than 3,000 quantitative and dichotomous traits, with separate analyses for common and rare classes of variation. Specifically, we highlight the effects of CNVs at two well-known syndromic loci 16p11.2 and 22q11.2, previously uncharacterized variation at 9p23, and several genic associations in the context of acute coronary artery disease and high body mass index. Our data constitute a deeply contextualized portrait of population-wide burden of copy-number variation, as well as a series of dosage-mediated genic associations across the medical phenome.

Related projects

The overall goal of this project is to study the causal roles of the 36 biomarkers currently being assayed in UK Biobank for development of…

Institution:
Stanford University, United States of America

We aim to better understand the contribution of genetic factors to variation in normal heart structure and to look for genes and genetic variation which…

Institution:
Stanford University, United States of America

This proposal seeks access to UK Biobank data to support efforts to identify genetic modifiers of polygenic disease risk with a specific focus on inflammatory…

Institution:
Broad Institute, United States of America

This proposal seeks access to UK Biobank data to support efforts to generate effect therapeutic hypotheses from genomic and hospital in-patient data. We have developed…

Institution:
Stanford University, United States of America

All projects